Head down tilt 15° for the treatment of intracerebral hemorrhage in rats


  • Head down tilt 15° (HDT15°) in the hyperacute phase of experimental intracerebral haemorrhage (ICH) does not worsen early outcome.

Why this matters

  • HDT15° applied before recanalization can increase collateral flow and improve outcome in experimental ischemic stroke.

  • Development and implementation of a “collateral therapeutic” is a major objective in stroke research. With its simplicity and low cost, HDT15° represents a good candidate as a collateral therapeutic that can be applied by emergency services.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.